Kenegix Product 01
Natural health product licensed in Canada
- Other names
- Prime D+, Real Ketones
- Licence holder
- Real Ketones, LLC
- NPN or DIN-HM
- 80092353
- Status
- Active licence
- Licence date
- 21 May 2019
- Revision date
- 10 March 2021
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Triglycérides à chaîne moyenne Source : Cocos nucifera - fruit flesh Potency : 47.81 % Octanoic acid | 4 g | Not calculated |
| Triglycérides à chaîne moyenne Source : Elaeis guineensis - Albumen (graine d'angiosperme) Potency : 47.81 % Octanoic acid | 4 g | Not calculated |
| D-3-Hydroxybutyrate Source : Potassium beta-Hydroxybutyrate | 3.12 g | Not calculated |
| D-3-Hydroxybutyrate Source : Bêta-hydroxybutyrate de magnésium | 3.12 g | Not calculated |
| D-3-Hydroxybutyrate Source : bêta-Hydroxybutyrate de Calcium | 3.12 g | Not calculated |
| D-3-Hydroxybutyrate Source : Bêta-hydroxybutyrate de sodium | 3.12 g | Not calculated |
| Triglycérides à chaîne moyenne Source : Cocos nucifera - fruit flesh Potency : 21.79 % Capric Acid | Not specified | Not calculated |
| Triglycérides à chaîne moyenne Source : Elaeis guineensis - Albumen (graine d'angiosperme) Potency : 21.79 % Capric Acid | Not specified | Not calculated |
Non-medicinal ingredients
Rébaudioside A, Acide citrique, Gomme de Guar, Dioxyde de silicium, Saveur, Bêta-carotène, Betterave rouge
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Mesures | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of caprylic acid, a medium chain fatty acid. Source of caprylic acid, a medium chain fatty acid, which contributes to energy metabolism and production. Source of caprylic acid, a medium chain fatty acid, which is a factor in energy metabolism and production. Source of Medium-Chain Fatty Acids which support energy production in the body. Source of Medium-Chain Fatty Acids and , which metabolize into ketones, providing the body with an alternative source of energy. Source of Medium-chain fatty acids which metabolize into ketones, providing an alternative source of cellular energy to body tissues, including the brain and muscles. Source of beta-hydroxybutyrate which increases blood beta-hydroxybutyrate levels and provides an alternative source of cellular energy (ATP) to body tissues.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80092353
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging